Tiverton Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Tiverton Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$4.29M	Buy	84,502 +21,907	+35%	+$1.03M	0.15%	136
2019 Q2	$2.84M	Buy	+62,595	New	+$2.92M	0.1%	166
2019 Q1	–	Sell	-20,596	Closed	-$1.07M	–	655
2018 Q4	$1.07M	Buy	+20,596	New	+$1.11M	0.06%	170
2018 Q2	–	Sell	-26,167	Closed	-$1.66M	–	422
2018 Q1	$1.66M	Buy	26,167 +532	+2%	+$34.2K	0.11%	125
2017 Q4	$1.57M	Buy	+25,635	New	+$1.6M	0.1%	164

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tiverton Asset Management's BMY Position: Q3 2019 in Review

Tiverton Asset Management increased its Bristol-Myers Squibb (BMY) stake by 35% in Q3 2019, buying an estimated $1.03M and bringing the position to 84,502 shares worth $4.29M. The position accounts for 0.15% of the portfolio, ranked #136.

Tiverton Asset Management first reported a position in BMY in Q4 2017 and has held it in 5 quarters since. 1,813 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

Tiverton Asset Management held 84,502 shares of Bristol-Myers Squibb worth $4.29M as of Q3 2019.
Tiverton Asset Management bought 21,907 Bristol-Myers Squibb shares in Q3 2019, an estimated $1.03M.
Bristol-Myers Squibb made up 0.15% of Tiverton Asset Management's portfolio in Q3 2019, its #136 holding.
Tiverton Asset Management first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 5 quarters since.
1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.